Just like you never want to hear a doctor say "oops" in the operating room, you never want to see a going-concern statement in a financial report about a company you own. Accountants throw these in when they've been over the books, talked to customers, and checked the horoscopes and have concluded there is "substantial doubt" about a company's ability to remain in business. In short, don't blame the accountants if the company files for bankruptcy protection.

You¿d reckon that a going-concern statement would be enough to send investors running to the exits, but it's not. True, many large institutions automatically bail when an existing company gets slapped with one of these, but many individuals (often wrongly) take a chance they know more than the bean counters.

During the tech boom of the late 1990s, many companies actually went public even though they had been hit with going-concern statements. Many of those companies subsequently disappeared. Enough said.

Home / Markets / Industries / Technology

Thursday, July 10, 2008

Phase Forward Announces Second Quarter Financial Reporting Date for July 28, 2008

Email this Story | Respond to Editor | Print

Comtex

WALTHAM, Mass., Jul 10, 2008 (BUSINESS WIRE) ----Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, announced today that it will release financial results for the quarter ended June 30, 2008 and hold a conference call with investors on Monday, July 28, 2008. The Company plans to hold the investor conference call, hosted by Bob Weiler, president and chief executive officer, and Rodger Weismann, senior vice president and chief financial officer, to discuss its second quarter 2008 financial results and its outlook for the third quarter and full year 2008. The call will be held on Monday, July 28, 2008, at 5:00 p.m. (EDT).

The investor conference call will be available via live webcast on Phase Forward's web site at www.phaseforward.com under the tab "Investors." To participate by telephone, the domestic dial-in number is 888-680-0890 and the international dial-in is 617-213-4857. The access code is 35453643. Investors are advised to dial into the call at least ten minutes prior to the call to register. Participants may pre-register for the call at www.theconferencingservice.com/prereg/key.process?key=PN4KA4XN3. Pre-registrants will be issued a pin number to use when dialing into the live call which will provide quick access to the conference by bypassing the operator upon connection.

The webcast will be available for replay until Monday, August 25, 2008 on the "Investors" page of Phase Forward's website.

About Phase Forward

Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. The company offers proven solutions for electronic data capture (InForm(TM)), phase I clinic automation (LabPas(TM)), clinical data management (Clintrial(TM)), clinical trials signal detection (CTSD(TM)), strategic pharmacovigilance (WebVDME(TM) and Signal Management), adverse event reporting (Empirica(TM) Trace) and applied data standards (WebSDM(TM)). In addition, the company provides services in the areas of application implementation, hosting and validation, data integration, business process optimization, safety data management and industry standards. Phase Forward's products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 280 organizations and regulatory agencies worldwide including: AstraZeneca, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration, GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono, Novartis, Novo Nordisk, PAREXEL International, Procter & Gamble, Quintiles, sanofi-aventis, Schering-Plough Research Institute, Servier, Tibotec and the U.K. Medicines and Healthcare Products Regulatory Agency. Additional information about Phase Forward is available at www.phaseforward.com.

SOURCE: Phase Forward Incorporated

Public Relations CHEN PR, Inc Barbara Heffner, 781-672-3112 bheffner@chenpr.com or Investor
   Relations Integrated Corporate Relations Timothy Dolan, 617-956-6727 tdolan@icrinc.com

Copyright Business Wire
   2008 ********************************************************************** As of Sunday, 07-06-2008 23:59, the latest Comtex
   SmarTrend� Alert, an automated pattern recognition system, indicated an UPTREND on 07-03-2008 for PFWD @ $18.76. For more
   information on SmarTrend, contact your market data provider or go to www.mysmartrend.com SmarTrend is a registered trademark
   of Comtex News Network, Inc. Copyright � 2004-2008 Comtex News Network, Inc. All rights reserved.